Primary Gastrointestinal <scp>EBV</scp>‐Associated Classical Hodgkin Lymphoma in Crohn Disease on Anti‐<scp>TNF</scp>‐α Therapy: A Rare Association

Primary intestinal CHL comprises less than 5% of gastrointestinal lymphomas; CHL arising in the context of Crohn disease is even more rare. Most lymphomas associated with inflammatory bowel disease and/or immunosuppression are non-Hodgkin type. In this case, the long-term treatment with anti-TNF-α and EBV positivity suggested an iatrogenic immunodeficiency-associated lymphoma, an emerging group of lymphoproliferative disorders associated with the increased use of immunosuppressants.